AUGENEMULSION

European patent · EP2506830 · In force

Register entry

Publication number
EP2506830
Application number
EP10785299
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 2, 2010
Published
Oct 10, 2012
Granted
Aug 24, 2016
Protection ends at the latest
Dec 1, 2030
Next annual fee due
Dec 31, 2026
IPC classes
A61K 9/00 (2006.01)
A61K 9/107 (2006.01)
A61K 47/24 (2006.01)
A61K 47/36 (2006.01)
A61K 47/02 (2006.01)
Priority
US 266207 P 03.12.2009
PCT application
PCT/US2010/058703 02.12.2010
PCT publication
WO2011/068955 09.06.2011
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Sep 22, 2021

    Transferred

    Owner
    Alcon Research, Ltd., 6201 South Freeway, Mail Code TB4-8, Fort Worth, TX 76134-2099, USA → Novartis AG, Lichtstrasse 35, 4056 Basel

    Published in Swissreg on 22.09.2021

  6. Dec 4, 2019

    Transferred

    Owner
    Novartis AG, Lichtstrasse 35, 4056 Basel → Alcon Inc., Rue Louis-d'Affry 6, 1701 Fribourg

    Published in Swissreg on 04.12.2019

  7. Aug 24, 2016

    Granted

    Published in Swissreg on 24.08.2016

Parties

Holder

Alcon AG

Alcon Inc.

Rue Louis-d'Affry 6, 1701 Fribourg

Inventor

KETELSON, Howard Allen

Dallas Texas 75235, US

MEADOWS, David L.

Colleyville Texas 76034, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.